Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad A. Alsallakh has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of abolishing prescription charges on asthma medication usage and clinical outcomes: a systematic review

    by Zihao Wang, Mohammad Al Sallakh, Aziz Sheikh, Jennifer K. Quint, Benoît Corriveau, Gwyneth A. Davies

    Summary: Objective: The impact of abolishing prescription charges on asthma medication use and clinical outcomes is uncertain. We aimed to investigate whether removing prescription charges improves asthma medication use, adherence and clinical outcomes. Design: Systematic review. Scopus, Web of Science and PubMed were searched for articles published between 1 January 2005 and 2 October 2025. Studies were screened, data extracted and risk of bias appraised. Findings were narratively synthesised by outcome domain. Setting: Free prescription policy interventions. Participants: Asthma or mixed respiratory chronic disease populations affected by free prescription policies. Main outcome measures: Asthma medication prescribing or dispensing, adherence or persistence and severe outcomes (asthma-related emergency department attendances and hospital admissions). Results: Of 122 identified records, five met the inclusion criteria, ranging from a 2259-patient UK-matched cohort to a Swedish population-level study of 485,665 children. All were observational and heterogeneous in policy exposure, population and outcome definition. Four studies reported prescribing or dispensing. Evidence was mixed: paediatric dispensing increased after fee removal in Sweden, from 46.3 to 51.1 defined daily doses per child per month, and a Canadian study reported an increase in controller days’ supply among low-income patients of 1.50 days per month (95% CI 0.61 to 2.40). However, two UK studies showed no consistent policy-attributable changes in asthma controller or reliever use. For adherence or persistence, two person-level studies from the UK and Canada found no improvement in adherence, whereas a Swedish before-and-after analysis showed paediatric asthma medication persistence increased from 48.3% to 52.2%. Four studies reported severe outcomes, but only two were asthma-specific, and causal attribution was limited. Conclusions: Evidence on free prescriptions policy on asthma outcomes is sparse and heterogeneous. These policies may improve asthma controller access in some settings, but the limited evidence available does not indicate consistent improvements in adherence or reductions in severe outcomes.

  • Open Access

    Impact of air pollution and asthma on school attendance and educational attainment: a scoping review

    by Cedric Burden, Zakariah Gassasse, Mohammed Alsallakh, Jennifer K Quint, Richard Fry, Gwyneth Davies

    Background: Asthma morbidity is high among young people, and studies have shown associations between asthma and school attendance and educational attainment. However, findings are unclear concerning associations between air pollution and these educational outcomes, and whether asthma might mediate any associations. Objective: This review aimed to summarise, and find gaps in, the research on outdoor air pollution, asthma and educational outcomes. To our knowledge, this is the first review to consider the impact of air pollution or asthma, individually or in combination, on the school attendance and educational attainment of children and young people. Design: This scoping review, using the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews method, reports on searches for English language studies of air pollution, asthma and school attendance and educational attainment in eight databases with tabulation and synthesis of the extracted data. Results: Association between air pollution and school absence was found to be weaker than for active asthma with this outcome. Uncontrolled asthma was associated with lower educational attainment, but findings on air pollution exposure were mixed. Two studies found associations for air pollution with poorer educational outcomes for young people with asthma. Long-term exposure to air pollution, and an increase in the frequency of peaks of air pollution, were associated with worse educational outcomes. Inequalities in access to healthcare and education were associated with uncontrolled asthma and lower educational outcomes. Only one study used linked health, environmental and educational data. Conclusions: Linked administrative data will be important to enable longitudinal studies of exceptionally large populations to explore asthma exacerbation, baseline and spikes of air pollution and risk factors. Analyses should control for type of educational assessment and specific particulate exposure. Studies should examine temporal changes and a variety of geographical settings to identify even weak associations to inform approaches to address inequalities of public health and education.

  • Open Access

    Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews

    by Elizabeth Moore, Mohammad Al Sallakh, Olufemi Olajide, Daira Trusinska, Tracy Jackson, Ting Shi, Sara J. Brown, Joanna C. Robson, Mwidimi Ndosi, Meghna Jani, et al.

    Purpose: Oral glucocorticoids (OGCs) have a broad range of uses and are effective in treating numerous conditions. However, it is commonly acknowledged that OGCs at high doses or over long periods have a burden of toxicity. Despite the use of steroid‐sparing therapies, OGCs continue to be prescribed to treat a wide range of immune and inflammatory conditions. We aimed to address the following research questions: (1) what are the contemporary indications for high dose and/or long‐term OGCs? (2) what patterns of use are described in the literature for high dose and/or long‐term OGCs? (3) which evidence do we have for chronic conditions related to well‐established steroid‐sparing strategies and tapering regimes for OGCs? (4) what adverse effects have been reported with high dose and/or long‐term OGCs? Methods: A rapid scoping review was conducted using the Joanna Briggs Institute guidelines. The Protocol has been published on the Open Science Framework. A systematic search of MEDLINE (Sep 2014 to Sep 2024) identified systematic reviews and scoping reviews involving adults (≥ 18 years) treated with high doses and/or long‐term OGCs for chronic inflammatory conditions. Studies involving pregnant women were excluded. Results: In total, 137 reviews were included. OGCs were indicated in 47 different conditions in dermatology, respiratory, gastrointestinal, hematology, immunology, rheumatology, and other miscellaneous categories. Across all specialties, OGCs were used either at high doses (at least 20 mg prednisone equivalent per day) or for long durations (for at least 3 months). For types of adverse effects reported in the included reviews, 20 were labeled as endocrine, 13 as immunological, 21 as musculoskeletal, 30 as gastrointestinal, and 16 as cardiovascular. Sixty‐four reviews looked for/reported unspecified adverse events. One hundred and fifteen reviews had evidence of steroid‐sparing/tapering regimes, indicating the wide use of these strategies to mitigate the harmful effects of OGCs. Conclusion: OGCs are used for a broad range of inflammatory conditions across multiple specialties. There is evidence related to a broad range of potential adverse effects across multiple body systems regardless of the indication of use. Further research is needed using a combined cross‐condition approach to their measurement and reduction, alongside gaining more insight into the impact of OGCs on patients' quality of life.


  • Open Access

    Impact of the COVID-19 Pandemic on Influenza Hospital Admissions and Deaths in Wales: Descriptive National Time Series Analysis

    by Mohammad Alsallakh, Davies Adeloye, Eleftheria Vasileiou, Shanya Sivakumaran, Ashley Akbari, Ronan A Lyons, Chris Robertson, Igor Rudan, Gwyneth A Davies, Aziz Sheikh

    Background: The COVID-19 pandemic and the ensuing implementation of control measures caused widespread societal disruption. These disruptions may also have affected community transmission and seasonal circulation patterns of endemic respiratory viruses. Objective: We aimed to investigate the impact of COVID-19–related disruption on influenza-related emergency hospital admissions and deaths in Wales in the first 2 years of the pandemic. Methods: A descriptive analysis of influenza activity was conducted using anonymized pathology, hospitalization, and mortality data from the Secure Anonymised Information Linkage Databank in Wales. The annual incidence of emergency hospitalizations and deaths with influenza-specific diagnosis codes between January 1, 2015, and December 31, 2021, was estimated. Case definitions of emergency hospitalization and death required laboratory confirmation with a polymerase chain reaction test. Trends of admissions and deaths were analyzed monthly and yearly. We conducted 2 sensitivity analyses by extending case definitions to include acute respiratory illnesses with a positive influenza test and by limiting admissions to those with influenza as the primary diagnosis. We also examined yearly influenza testing trends to understand changes in testing behavior during the pandemic. Results: We studied a population of 3,235,883 Welsh residents in 2020 with a median age of 42.5 (IQR 22.9–61.0) years. Influenza testing in Wales increased notably in the last 2 months of 2020, and particularly in 2021 to 39,720 per 100,000 people, compared to the prepandemic levels (1343 in 2019). The percentage of influenza admissions matched to an influenza polymerase chain reaction test increased from 74.8% (1890/2526) in 2019 to 85.2% (98/115) in 2021. However, admissions with a positive test per 100,000 population decreased from 17.0 in 2019 to 2.7 and 0.6 in 2020 and 2021, respectively. Similarly, deaths due to influenza with a positive influenza test per 100,000 population decreased from 0.4 in 2019 to 0.0 in 2020 and 2021. Sensitivity analyses showed similar patterns of decreasing influenza admissions and deaths in the first 2 years of the COVID-19 pandemic. Conclusions: Nonpharmaceutical interventions to control COVID-19 were associated with a substantial reduction in the transmission of the influenza virus, with associated substantial reductions in hospital cases and deaths observed. Beyond the pandemic context, consideration should be given to the role of nonpharmaceutical community-driven interventions to reduce the burden of influenza.


  • Open Access

    Estimating the contribution of respiratory pathogens to acute exacerbations of COPD using routine data

    by Shanya Sivakumaran, Mohammad A. Alsallakh, Ronan A. Lyons, Jennifer K. Quint, Gwyneth A. Davies


  • Open Access

    Patterns of Healthcare Resource Utilisation of Critical Care Survivors between 2006 and 2017 in Wales: A Population-Based Study

    by Mohammad Alsallakh, Laura Tan, Richard Pugh, Ashley Akbari, Rowena Bailey, Rowena Griffiths, Ronan A. Lyons, Tamas Szakmany

    In this retrospective cohort study, we used the Secure Anonymised Information Linkage (SAIL) Databank to characterise and identify predictors of the one-year post-discharge healthcare resource utilisation (HRU) of adults who were admitted to critical care units in Wales between 1 April 2006 and 31 December 2017. We modelled one-year post-critical-care HRU using negative binomial models and used linear models for the difference from one-year pre-critical-care HRU. We estimated the association between critical illness and post-hospitalisation HRU using multilevel negative binomial models among people hospitalised in 2015. We studied 55,151 patients. Post-critical-care HRU was 11–87% greater than pre-critical-care levels, whereas emergency department (ED) attendances decreased by 30%. Age ≥50 years was generally associated with greater post-critical-care HRU; those over 80 had three times longer hospital readmissions than those younger than 50 (incidence rate ratio (IRR): 2.96, 95% CI: 2.84, 3.09). However, ED attendances were higher in those younger than 50. High comorbidity was associated with 22–62% greater post-critical-care HRU than no or low comorbidity. The most socioeconomically deprived quintile was associated with 24% more ED attendances (IRR: 1.24 [1.16, 1.32]) and 13% longer hospital stays (IRR: 1.13 [1.09, 1.17]) than the least deprived quintile. Critical care survivors had greater 1-year post-discharge HRU than non-critical inpatients, including 68% longer hospital stays (IRR: 1.68 [1.63, 1.74]). Critical care survivors, particularly those with older ages, high comorbidity, and socioeconomic deprivation, used significantly more primary and secondary care resources after discharge compared with their baseline and non-critical inpatients. Interventions are needed to ensure that key subgroups are identified and adequately supported.


  • Open Access

    Identifying COPD in routinely collected electronic health records: a systematic scoping review

    by Shanya Sivakumaran, Mohammad A. Alsallakh, Ronan A. Lyons, Jennifer K. Quint, Gwyneth A. Davies

    Although routinely collected electronic health records (EHRs) are widely used to examine outcomes related to COPD, consensus regarding the identification of cases from electronic healthcare databases is lacking. We systematically examine and summarise approaches from the recent literature.MEDLINEviaEBSCOhost was searched for COPD-related studies using EHRs published from January 1, 2018 to November 30, 2019. Data were extracted relating to the case definition of COPD and determination of COPD severity and phenotypes.From 185 eligible studies, we found widespread variation in the definitions used to identify people with COPD in terms of code sets used (with 20 different code sets in use based on the ICD-10 classification alone) and requirement of additional criteria (relating to age (n=139), medication (n=31), multiplicity of events (n=21), spirometry (n=19) and smoking status (n=9)). Only seven studies used a case definition which had been validated against a reference standard in the same dataset. Various proxies of disease severity were used since spirometry results and patient-reported outcomes were not often available.To enable the research community to draw reliable insights from EHRs and aid comparability between studies, clear reporting and greater consistency of the definitions used to identify COPD and related outcome measures is key.


  • Open Access

    Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales

    by On Behalf Of The Eave Ii Collaborators, Mohammad A. Alsallakh, Shanya Sivakumaran, Sharon Kennedy, Eleftheria Vasileiou, Ronan A. Lyons, Chris Robertson, Aziz Sheikh, Gwyneth A. Davies

    Background: The COVID-19 pandemic and ensuing national lockdowns have dramatically changed the healthcare landscape. The pandemic’s impact on people with chronic obstructive pulmonary disease (COPD) remains poorly understood. We hypothesised that the UK-wide lockdown restrictions were associated with reductions in severe COPD exacerbations. We provide the first national level analyses of the impact of the COVID-19 pandemic and first lockdown on severe COPD exacerbations resulting in emergency hospital admissions and/or leading to death as well as those recorded in primary care or emergency departments. Methods: Using data from Public Health Scotland and the Secure Anonymised Information Linkage Databank in Wales, we accessed weekly counts of emergency hospital admissions and deaths due to COPD over the first 30 weeks of 2020 and compared these to the national averages over the preceding 5 years. For both Scotland and Wales, we undertook interrupted time-series analyses to model the impact of instigating lockdown on these outcomes. Using fixed-effect meta-analysis, we derived pooled estimates of the overall changes in trends across the two nations. Results: Lockdown was associated with 48% pooled reduction in emergency admissions for COPD in both countries (incidence rate ratio, IRR 0.52, 95% CI 0.46 to 0.58), relative to the 5-year averages. There was no statistically significant change in deaths due to COPD (pooled IRR 1.08, 95% CI 0.87 to 1.33). In Wales, lockdown was associated with 39% reduction in primary care consultations for acute exacerbation of COPD (IRR 0.61, 95% CI 0.52 to 0.71) and 46% reduction in COPD-related emergency department attendances (IRR 0.54, 95% CI 0.36 to 0.81). Conclusions: The UK-wide lockdown was associated with the most substantial reductions in COPD exacerbations ever seen across Scotland and Wales, with no corresponding increase in COPD deaths. This may have resulted from reduced transmission of respiratory infections, reduced exposure to outdoor air pollution and/or improved COPD self-management.


  • Open Access

    Long‐term trends in critical care admissions in Wales* *

    by R. J. Pugh, R. Bailey, T. Szakmany, M. Al Sallakh, J. Hollinghurst, A. Akbari, R. Griffiths, C. Battle, C. Thorpe, C. P. Subbe, et al.

    Summary: As national populations age, demands on critical care services are expected to increase. In many healthcare settings, longitudinal trends indicate rising numbers and proportions of patients admitted to ICU who are older; elsewhere, including some parts of the UK, a decrease has raised concerns with regard to rationing according to age. Our aim was to investigate admission trends in Wales, where critical care capacity has not risen in the last decade. We used the Secure Anonymised Information Linkage Databank to identify and characterise critical care admissions in patients aged ≥ 18 years from 1 January 2008 to 31 December 2017. We categorised 85,629 ICU admissions as youngest (18–64 years), older (65–79 years) and oldest (≥ 80 years). The oldest group accounted for 15% of admissions, the older age group 39% and the youngest group 46%. Relative to the national population, the incidence of admission rates per 10,000 population in the oldest group decreased significantly over the study period from 91.5/10,000 in 2008 to 77.5/10,000 (a relative decrease of 15%), and among the older group from 89.2/10,000 in 2008 to 75.3/10,000 in 2017 (a relative decrease of 16%). We observed significant decreases in admissions with high comorbidity (modified Charlson comorbidity index); increases in the proportion of older patients admitted who were considered ‘fit’ rather than frail (electronic frailty index); and decreases in admissions with a medical diagnosis. In contrast to other healthcare settings, capacity constraints and surgical imperatives appear to have contributed to a relative exclusion of older patients presenting with acute medical illness.


  • Open Access

    Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales

    by Gwyneth A Davies, Mohammad A Alsallakh, Shanya Sivakumaran, Eleftheria Vasileiou, Ronan A Lyons, Chris Robertson, Aziz Sheikh

    Background The COVID-19 pandemic’s impact on people with asthma is poorly understood. We hypothesised that lockdown restrictions were associated with reductions in severe asthma exacerbations requiring emergency asthma admissions and/or leading to death. Methods Using data from Public Health Scotland and the Secure Anonymised Information Linkage Databank in Wales, we compared weekly counts of emergency admissions and deaths due to asthma over the first 18 weeks in 2020 with the national averages over 2015–2019. We modelled the impact of instigating lockdown on these outcomes using interrupted time-series analysis. Using fixed-effect meta-analysis, we derived pooled estimates of the overall changes in trends across the two nations. We also investigated trends in asthma-related primary care prescribing and emergency department (ED) attendances in Wales. Results Lockdown was associated with a 36% pooled reduction in emergency admissions for asthma (incidence rate ratio, IRR: 0.64, 95% CI: 0.49 to 0.83, p value 0.001) across both countries. There was no significant change in asthma deaths (pooled IRR: 0.57, 95% CI: 0.17 to 1.94, p value 0.37). ED asthma attendances in Wales declined during lockdown (IRR: 0.85, 95% CI: 0.73 to 0.99, p value 0.03). A large spike of 121% more inhaled corticosteroids and 133% more oral corticosteroid prescriptions was seen in Wales in the week before lockdown. Conclusions National lockdowns were associated with substantial reductions in severe asthma exacerbations leading to hospital admission across both Scotland and Wales, with no corresponding increase in asthma deaths.